Literature DB >> 24819148

Hippocampal sclerosis dementia with the C9ORF72 hexanucleotide repeat expansion.

Olga Pletnikova1, Kelly L Sloane2, Alan E Renton3, Bryan J Traynor4, Barbara J Crain1, Tammy Reid5, Tao Zu5, Laura P W Ranum5, Juan C Troncoso6, Peter V Rabins2, Chiadi U Onyike7.   

Abstract

Frontotemporal dementia (FTD) and amyotrophic lateral sclerosis (ALS) are the main syndromes of the chromosome 9 ORF72 (C9ORF72) hexanucleotide repeat expansion, but studies have shown a substantial phenotypic diversity that includes psychiatric presentations. This study describes hippocampal sclerosis dementia (HSD) in carriers of the C9ORF72 mutation. We compared clinical and neuropathological features of HSD in carriers and noncarriers autopsied at Johns Hopkins. Carriers presented with amnesia, agitation, dissocial behavior, and impaired self-care, whereas noncarriers showed little agitation. The groups were not dissimilar in cognitive or motor dysfunction. Neuropathological examination of carriers showed cerebellar neuronal inclusions positive for ubiquitin, p62, and ubiquilin-2, and negative for TAR DNA-binding protein 43. Noncarriers did not have cerebellar inclusions. C9ORF72 repeat-associated non-ATG translation was confirmed by immunohistochemistry. These observations broaden the C9ORF72 phenotype and place HSD in the FTD spectrum. The amnesic phenotype of HSD, which is consistent with the focal hippocampal atrophy, should be included in clinical categorizations of FTD.
Copyright © 2014 Elsevier Inc. All rights reserved.

Entities:  

Keywords:  C9ORF72 hexanucleotide repeat expansion; Dementia; Frontotemporal dementia; Hippocampal sclerosis

Mesh:

Substances:

Year:  2014        PMID: 24819148      PMCID: PMC4087047          DOI: 10.1016/j.neurobiolaging.2014.04.009

Source DB:  PubMed          Journal:  Neurobiol Aging        ISSN: 0197-4580            Impact factor:   4.673


  42 in total

1.  The Consortium to Establish a Registry for Alzheimer's Disease (CERAD). Part II. Standardization of the neuropathologic assessment of Alzheimer's disease.

Authors:  S S Mirra; A Heyman; D McKeel; S M Sumi; B J Crain; L M Brownlee; F S Vogel; J P Hughes; G van Belle; L Berg
Journal:  Neurology       Date:  1991-04       Impact factor: 9.910

2.  Hippocampal sclerosis dementia with tauopathy.

Authors:  Thomas G Beach; Lucia Sue; Sarah Scott; Kathryn Layne; Amanda Newell; Douglas Walker; Matthew Baker; Naraju Sahara; Shu-Hui Yen; Michael Hutton; Richard Caselli; Charles Adler; Donald Connor; Marwan Sabbagh
Journal:  Brain Pathol       Date:  2003-07       Impact factor: 6.508

3.  Pick's disease. Histological and clinical correlations.

Authors:  J Constantinidis; J Richard; R Tissot
Journal:  Eur Neurol       Date:  1974       Impact factor: 1.710

Review 4.  Staging of Alzheimer's disease-related neurofibrillary changes.

Authors:  H Braak; E Braak
Journal:  Neurobiol Aging       Date:  1995 May-Jun       Impact factor: 4.673

5.  Hippocampal sclerosis contributes to dementia in the elderly.

Authors:  J Corey-Bloom; M N Sabbagh; M W Bondi; L Hansen; M F Alford; E Masliah; L J Thal
Journal:  Neurology       Date:  1997-01       Impact factor: 9.910

6.  Pure hippocampal sclerosis: a rare cause of dementia mimicking Alzheimer's disease.

Authors:  T A Ala; G O Beh; W H Frey
Journal:  Neurology       Date:  2000-02-22       Impact factor: 9.910

7.  Hippocampal sclerosis: a common pathological feature of dementia in very old (> or = 80 years of age) humans.

Authors:  D W Dickson; P Davies; C Bevona; K H Van Hoeven; S M Factor; E Grober; M K Aronson; H A Crystal
Journal:  Acta Neuropathol       Date:  1994       Impact factor: 17.088

Review 8.  Most cases of dementia with hippocampal sclerosis may represent frontotemporal dementia.

Authors:  K J Hatanpaa; D M Blass; O Pletnikova; B J Crain; E H Bigio; J C Hedreen; C L White; J C Troncoso
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

9.  Dementia in hippocampal sclerosis resembles frontotemporal dementia more than Alzheimer disease.

Authors:  D M Blass; K J Hatanpaa; J Brandt; V Rao; M Steinberg; J C Troncoso; P V Rabins
Journal:  Neurology       Date:  2004-08-10       Impact factor: 9.910

10.  RAN proteins and RNA foci from antisense transcripts in C9ORF72 ALS and frontotemporal dementia.

Authors:  Tao Zu; Yuanjing Liu; Monica Bañez-Coronel; Tammy Reid; Olga Pletnikova; Jada Lewis; Timothy M Miller; Matthew B Harms; Annet E Falchook; S H Subramony; Lyle W Ostrow; Jeffrey D Rothstein; Juan C Troncoso; Laura P W Ranum
Journal:  Proc Natl Acad Sci U S A       Date:  2013-11-18       Impact factor: 11.205

View more
  10 in total

Review 1.  Update on Hippocampal Sclerosis.

Authors:  Juliana R Dutra; Etty P Cortés; Jean Paul G Vonsattel
Journal:  Curr Neurol Neurosci Rep       Date:  2015-10       Impact factor: 5.081

Review 2.  A clinicopathological approach to the diagnosis of dementia.

Authors:  Fanny M Elahi; Bruce L Miller
Journal:  Nat Rev Neurol       Date:  2017-07-14       Impact factor: 42.937

3.  Detection of TDP-43 oligomers in frontotemporal lobar degeneration-TDP.

Authors:  Patricia F Kao; Yun-Ru Chen; Xiao-Bo Liu; Charles DeCarli; William W Seeley; Lee-Way Jin
Journal:  Ann Neurol       Date:  2015-06-30       Impact factor: 10.422

Review 4.  Hippocampal Sclerosis, Argyrophilic Grain Disease, and Primary Age-Related Tauopathy.

Authors:  Gregory A Jicha; Peter T Nelson
Journal:  Continuum (Minneap Minn)       Date:  2019-02

5.  Viral delivery of C9orf72 hexanucleotide repeat expansions in mice leads to repeat-length-dependent neuropathology and behavioural deficits.

Authors:  Saul Herranz-Martin; Jayanth Chandran; Katherine Lewis; Padraig Mulcahy; Adrian Higginbottom; Callum Walker; Isabel Martinez-Pena Y Valenzuela; Ross A Jones; Ian Coldicott; Tommaso Iannitti; Mohammed Akaaboune; Sherif F El-Khamisy; Thomas H Gillingwater; Pamela J Shaw; Mimoun Azzouz
Journal:  Dis Model Mech       Date:  2017-05-26       Impact factor: 5.758

6.  Phenotypic variability and neuropsychological findings associated with C9orf72 repeat expansions in a Bulgarian dementia cohort.

Authors:  Shima Mehrabian; Håkan Thonberg; Margarita Raycheva; Lena Lilius; Katya Stoyanova; Charlotte Forsell; Lena Cavallin; Desislava Nesheva; Eric Westman; Draga Toncheva; Latchezar Traykov; Bengt Winblad; Caroline Graff
Journal:  PLoS One       Date:  2018-12-14       Impact factor: 3.240

7.  An interaction between synapsin and C9orf72 regulates excitatory synapses and is impaired in ALS/FTD.

Authors:  Claudia S Bauer; Rebecca N Cohen; Francesca Sironi; Matthew R Livesey; Thomas H Gillingwater; J Robin Highley; Daniel J Fillingham; Ian Coldicott; Emma F Smith; Yolanda B Gibson; Christopher P Webster; Andrew J Grierson; Caterina Bendotti; Kurt J De Vos
Journal:  Acta Neuropathol       Date:  2022-07-25       Impact factor: 15.887

Review 8.  Phenotypic Heterogeneity of Monogenic Frontotemporal Dementia.

Authors:  Alberto Benussi; Alessandro Padovani; Barbara Borroni
Journal:  Front Aging Neurosci       Date:  2015-09-01       Impact factor: 5.750

9.  G-quadruplex structures formed by expanded hexanucleotide repeat RNA and DNA from the neurodegenerative disease-linked C9orf72 gene efficiently sequester and activate heme.

Authors:  Jason C Grigg; Nisreen Shumayrikh; Dipankar Sen
Journal:  PLoS One       Date:  2014-09-10       Impact factor: 3.240

Review 10.  RAN translation and frameshifting as translational challenges at simple repeats of human neurodegenerative disorders.

Authors:  Marzena Wojciechowska; Marta Olejniczak; Paulina Galka-Marciniak; Magdalena Jazurek; Wlodzimierz J Krzyzosiak
Journal:  Nucleic Acids Res       Date:  2014-09-12       Impact factor: 16.971

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.